VP Clinical Development

In a nutshell:

The Vice President, Clinical Development will own and lead all sponsor-led clinical development activities at Resilience across oncology, gastroenterology, and psychiatry.

This role is accountable for the strategic direction, design, and execution of Resilience-sponsored clinical trials and real-world evidence programs, ensuring consistency, scientific rigor, operational excellence, and regulatory readiness across all business units.

Reporting to the Chief Medical Officer, the VP Clinical Development will build and lead a centralized Clinical Development organization, composed of Clinical Leads and Clinical Scientists, and will serve as the single point of accountability for clinical development execution at the company level.

• Own the end-to-end clinical development strategy and execution for all Resilience-sponsored studies
• Provide senior clinical leadership on:
• study design and methodology
• protocol development and amendments
• endpoint selection and clinical relevance
• interpretation of clinical and real-world evidence
• Ensure alignment and consistency of clinical development approaches across oncology, gastroenterology, and psychiatry

Team Leadership & Organization

• Build, lead, and mentor a Clinical Development team composed of:
• Clinical Leads (by therapeutic area)
• Clinical Scientists
• Define clear roles, responsibilities, and governance across the team
• Establish scalable ways of working enabling high-quality, timely execution

Portfolio Governance & Standardization

• Design and implement standardized clinical development frameworks across business units
• Harmonize:
• protocol templates and study documentation
• clinical review and governance processes
• decision criteria and escalation pathways
• Ensure alignment with ICH-GCP, ISO 14155, MDR, and applicable regulatory standards

Operational Excellence & Inspection Readiness

• Ensure inspection readiness across all sponsor-led trials
• Partner closely with Clinical Operations to:
• drive execution excellence and risk anticipation
• ensure quality-by-design principles
• resolve complex operational or scientific issues
• Act as senior escalation point for clinical development matters

Cross-Functional Leadership

• Collaborate closely with:
• Regulatory & Quality (clinical strategy, submissions, audits)
• Biostatistics (study design, endpoints, analysis plans)
• Medical Affairs (scientific alignment and evidence narratives)
• Market Access & Public Affairs (clinical evidence support)
• Product and Data teams (translation of clinical insights into digital solutions)
• Ensure clinical development is tightly integrated with company-wide priorities